Laser vaporization in the management of CIN

Aims: To evaluate the effectiveness of laser CO2 vaporization in high-grade cervical intraepithelial neoplasias and to assess the diagnostic reliability of cytology, colposcopy, microbiology and HPV tests in predicting recurrence in a long-term outcome. Methods: Forty-four patients affectd by high-grade cervical intraepithelial neoplasia (HG-CIN) were submitted to laser CO2 vapor-ization and followed-up a minimum of five years. Vaginal smears for microbiological examination were detected. HPV testing was performed by polymerase chain reaction (PCR). Results: The average age of the patients was 19.5 years (range 15-24). The cure rate after a single treatment was 95%. Two cases (5%) revealed HG-CIN persistence after three months. The five year follow-up of all cases submitted to a second laser procedure revealed negative cytologic and colposcopic findings. Conclusions: A higher degree of expertise and experience from the colposcopist and long-term follow-up proves the effectiveness of laser vaporization in the management of CIN in young women. It has been suggested that HPV infection alone may not be sufficient to promote carcinogenesis and that other cofactors could be involved. Microbiological tests are important to identify and treat any inflammation which might represent a cofactor of HPV infection in the pathogenesis of cervical dysplasia. Cytocolposcopic long-term follow-up, microbiological and HPV tests can improve regression of disease.

Cervical intraepithelial neoplasia; HPV; Recurrence; Adolescents.

[1] Ferlay J., Bray F., Pisani P., Parkin D.M.: “Globocan 2002 cancer incidence. Mortality and prevalence worldwide”. IARC CancerBase, No. 5, version 2.0. Lyon, IARC Press, 2004 .

[2] Munoz N., Castellsagué X., Berrington de Gonzalez A., Gissmann L.: “HPV in the etiology of human cancer”. Vaccine, 2006, 24, 1.

[3] Trottier H., Franco E.L.: “The epidemiology of genital human papillomavirus infection”. Vaccine, 2006, 24, 4.

[4] Mathevet P., Chemali E., Roy M., Dargent D.: “Long-term out-come of a randomized study comparing three techniques of conization: cold knife, laser, and LEEP”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2003, 106, 214.

[5] Pearson S.E., Whittaker J., Ireland D., Monaghan J.M.: “Invasive cancer of the cervix after laser treatment”. Br. J. Obstet. Gynaecol., 1989, 96, 486.

[6] Anderson M.C.: “Invasive carcinoma of the cervix following local destructive treatment for cervical intraepithelial neoplasia”. Br. J. Obstet. Gynaecol., 1993, 100, 657.

[7] Schmidt C., Pretorius R.G., Bonin M., Hanson L., Semrad N., Watring W.: “Invasive cervical cancer following cryotherapy for cervical intraepithelial neoplasia or human papillomavirus infec-tion”. Obstet. Gynecol., 1992, 80, 797.

[8] Soutter W.P., de Barros Lopes A., Fletcher A., Monaghan J.M., Duncan I.D. et al.: “Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia”. Lancet, 1997, 349, 978.

[9] Jordan J.A., Woodman C.B., Mylotte M.J., Emens J.M., Williams D. R., MacAlary M., Wade-Evans T.: “The treatment of cervical intraepithelial neoplasia by laser vaporization”. Br. J. Obstet. Gynaecol., 1985, 92, 394.

[10] Higgins R.V., van Nagell J.R. Jr, Donaldson E.S., Gallion H.H., Pavlik E.J., Kryscio R.J.: “The efficacy of laser therapy in the treat-ment of cervical intraepithelial neoplasia”. Gynecol. Oncol., 1990, 36, 79.

[11] Benedet J.L., Nickerson K.G., White G.W.: “Laser therapy for cervical intraepithelial neoplasia”. Obstet. Gynecol., 1981, 58, 188.

[12] Fallani M.G., Penna C., Fambrini M., Marchionni M.: “Laser CO2 vaporization for high-grade cervical intraepithelial neoplasia: a long-term follow-up series”. Gynecol. Oncol., 2003, 91, 130.

[13] Falcone T., Ferenczy A.: “Cervical intraepithelial neoplasia and condyloma: an analysis of diagnostic accuracy of posttreatment follow-up methods”. Am. J. Obstet. Gynecol., 1986, 154, 260.

[14] Pete I., Toth V., Bosze P.: “The value of colposcopy in screening cervical carcinoma”. Eur. J. Gynaecol. Oncol., 1998, 19, 120.

[15] Rokyta Z.: “Diagnostic reliability of prebioptic methods in the prediction of a histological basis of cervical lesions and its correlation with accuracy of colposcopically directed biopsy in patients with cervical neoplasia”. Eur. J. Gynaecol. Oncol., 2000, 21, 484.

[16] Davison J.M., Marty J.J.: “Detecting premalignant cervical lesions. Contribution of screening colposcopy to cytology”. J. Reprod. Med., 1994, 39, 388.

[17] Smith E.M., Johnson S.R., Ritchie J.M., Feddersen D., Wang D., Turek L.P., Haugen T.H.: “Persistent HPV infection in postmenopausal age women”. Int. J. Gynaecol. Obstet., 2004, 87, 131.

[18] Lukic A., Canzio C., Patella A., Giovagnoli M.R., Cipriani P., Frega A., Moscarini M.: “Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of ureaplasma urealyticum”. Anticancer Res., 2006, 26, 4843.

[19] The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. J. Reprod. Med., 1992, 37, 383.

[20] Vecchione A., Zanesi N., Trombetta G., French D., Visca P., Pisani T. et al.: “Cervical dysplasia, ploidy, and human papillomavirus status correlate with loss of Fhit expression”. Clin. Cancer Res., 2001, 7, 1306.

[21] Stafl A., Wilbanks G.D.: “An international terminology of colposcopy: report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy”. Obstet. Gynecol., 1991, 77, 313.

[22] Jones H.W. III (ed.): Bailliere’s Clinical Obstetric and Gynaecology. Cervical Intraepithelial Neoplasia, 1995, 9, 221.

[23] Ferenczy A.:“ Management of patients with high grade squamous intraepithelial lesions”. Cancer, 1995, 15, 1928.

[24] Mosciski A.B., Schiffman M., Kjaer S., Villa L.L.: “Updating the natural history of HPV and anogenital cancer”. Vaccine, 2006, 24, 42.

[25] Bornstein J., Rahat M.A., Abramovici H.: “Etiology of cervical cancer: current concepts”. Obstet. Gynecol. Surv., 1995, 60, 146. Castellsaguè X., Bosch F.X., Munoz N.: “Environmental cofactors in HPV carcinogenesis”. Vir. Res., 2002, 89, 191.

[27] Castel P.E., Giuliano A.R.: “Genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors”. J. Natl. Cancer Inst. Monographs, 2003, 31, 4.

[28] Castle P.E., Hillier S.L., Rabe L.K., Hidesheim A., Herrero R., Bratti M.C., Sherman M.E.: “An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV)”. Cancer Epid. Biom. Prev., 2001, 10, 1021.

[29] Smith J.S., Munoz N., Herrero R.; “Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines”. J. Infect Dis., 2002, 185, 324.

[30] Tamin H., Finan R.R., Sharida H.E., Rashid M., Almawi W.Y.: “Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis”. Diagn. Microb. Infect. Dis., 2002, 43, 277.

[31] Fisher N.: “Chlamydia trachomatis infection in cervical intraep-ithelial neoplasia and invasive carcinoma”. Eur. J. Gynecol. Oncol., 2002, 3, 247.

[32] Edelman M., Fox A., Alderman E.: “Cervical papanicolau smear abnormalities and chlamydia trachomatis in sexually active adolescent females”. J. Pediatr. Adolesc. Gynecol., 2000, 13, 65.

[33] Pisani S., Gallinelli C., Seganti A.: “Detection of viral and bacterial infections in women with normal and abnormal colposcopy”. Eur. J. Gynecol. Oncol., 1999, 20, 69.

[34] Guijon F., Paraskevas M., Rand F.: “Vaginal microbial flora as a cofactor in the pathogenesis of uterine cervical intraepithelial neoplasia”. Int. J. Gynecol. Obstet., 1992, 37, 185.